Filtered By:
Condition: Stroke
Vaccination: Vaccines
This page shows you your search results in order of date. This is page number 12.
Order by Relevance | Date
Total 855 results found since Jan 2013.
The trends and determinants of seasonal influenza vaccination after cardiovascular events in Canada: a repeated, pan-Canadian, cross-sectional study
CONCLUSION: Influenza vaccination is still at less than the recommended level in patients with CVD. Future research should consider the impact of interventions to improve vaccination uptake in this population.PMID:36794825 | DOI:10.24095/hpcdp.43.2.04
Source: Health Promotion and Chronic Disease Prevention in Canada - February 16, 2023 Category: International Medicine & Public Health Authors: Hanna Cho Sherilyn J D Houle Wasem Alsabbagh Source Type: research
Janssen Data at ASCO GU Support Ambition to Transform Treatment of Prostate and Bladder Cancer Through Precision Medicine and Early Intervention
RARITAN, N.J., February 13, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced plans to present more than 20 abstracts featuring seven oncology therapies from its robust portfolio and pipeline at the annual American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, taking place in San Francisco on February 16-18. Building on more than a decade of leadership in the development of medicines for people diagnosed with GU cancers, Janssen will present data demonstrating its ambition to advance patient-centered treatment through precision medicine, real-world evidence a...
Source: Johnson and Johnson - February 13, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Inactivated whole-virion SARS-CoV-2 vaccines and long-term clinical outcomes in patients with coronary atherosclerosis disease in China: a prospective cohort study
CONCLUSIONS: Our results indicated no evidence of an increased ischemic or bleeding risk after vaccination with inactivated SARS-CoV-2 vaccine among Chinese patients with CAD, with limited statistical power.PMID:36756815 | DOI:10.1093/cvr/cvad031
Source: Atherosclerosis - February 9, 2023 Category: Cardiology Authors: Huajie Xu Jiaojiao Zheng Xin Zhao Qi Zhou Bing Fan Hongyi Wu Si Zhang Junbo Ge Source Type: research
Herpes zoster and long-term vascular risk: a retrospective cohort study
Sci Rep. 2023 Feb 9;13(1):2364. doi: 10.1038/s41598-023-29667-w.ABSTRACTHerpes zoster (HZ) represents a serious health problem in the general population due to its abundance and complications. Stroke and acute myocardial infarction are well-documented short-term complications of HZ, primarily due to vasculopathy in the cerebral and coronary arteries. However, no major study to date has specifically demonstrated that HZ is a long-term risk factor for all Major Adverse Cardiac and Cerebrovascular Events (MACCE). A retrospective cohort study was conducted analyzing the association between HZ and MACCE. We compared HZ patients...
Source: Herpes - February 9, 2023 Category: Infectious Diseases Authors: Amir Horev Anat Horev Adi Gordon-Irshai Michal Gordon Nicolas Andre Gal Ifergane Source Type: research
Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection
To the Editor We would like to highlight some key points about the recent article that reported that patients who received full vaccination against COVID-19 had a reduced risk of acute myocardial infarction (AMI) and ischemic stroke after COVID-19 diagnosis.
Source: JAMA - February 7, 2023 Category: General Medicine Source Type: research
Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection —Reply
In Reply We thank Dr Chu and colleagues for their comments about our Research Letter. Our analysis found that 2 doses of COVID-19 vaccine were associated with a reduced risk of AMI and ischemic stroke after COVID-19, using inverse probability treatment weighting to mitigate the imbalance in patient characteristics by vaccination status.
Source: JAMA - February 7, 2023 Category: General Medicine Source Type: research
The U.S. Still Doesn ’ t Have Good COVID-19 Data. Here ’ s Why That ’ s a Problem
Check the COVID-19 Data Tracker from the U.S. Centers for Disease Control and Prevention (CDC), and you’ll get a rundown of the latest case numbers, hospitalizations, and deaths. Those categories might seem straightforward, but the data, say many experts, are telling us a lot less than we think they are.
That’s because it’s getting increasingly difficult to parse who is hospitalized or dies from COVID-19, and who is hospitalized or dies from another reason but with COVID-19. Across the U.S., “COVID-19 hospitalizations” represent all kinds of patients: those who need hospital-level care for sev...
Source: TIME: Health - January 30, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
FDA Experts Vote to Make All COVID-19 Vaccines and Boosters Bivalent
In a unanimous decision, all 21 voting members of the U.S. Food and Drug Administration’s (FDA) vaccine committee recommended that the U.S. start using the same COVID-19 virus strain in all of the COVID-19 vaccines, including primary and booster doses.
That means the bivalent booster dose, which targets both the original SARS-CoV-2 strain and the Omicron BA.4/5 strains, would soon become the only type used for all primary shots and boosters.
The decision reflects a turning point in the pandemic. Until now, vaccine makers have tried to keep up with constantly evolving variants, but they’ve always been a few step...
Source: TIME: Health - January 27, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Comment on vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine
Dear Editor, we would like to share ideas on the publication “Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study1.” If these symptoms are a minor form of VITT, with a possibility for worsening, such as in the case of a second vaccination dose, or a new entity of vaccine consequences, Schultz et al. ex plored this1. The combination of headaches and subcutaneous hemorrhage, according to Schultz et al., did not indicate VITT, and no other distinct coagulation problem or cerebral pathology was discovered.
Source: Journal of Stroke and Cerebrovascular Diseases - January 23, 2023 Category: Neurology Authors: Rujittika Mungmunpuntipantip, Viroj Wiwanitkit Tags: Letter to the Editor Source Type: research
Response to Letter to the Editor
We thank the authors for their interest in our article and the thoughtful comments. As they correctly point out, the association between the first vaccination with ChAdOx1 nCov -19 vaccine and the described symptoms in our article does not prove any causality. However, cutaneous hemorrhages and headaches were frequently reported side effects after vaccination with ChAdOx1 nCov-19 in the Norwegian corona study cohort in young and previously healthy subjects. In lack of previous experience, there was a fear that these symptoms may have represented a mild form of VITT.
Source: Journal of Stroke and Cerebrovascular Diseases - January 20, 2023 Category: Neurology Tags: Letter to the Editor Source Type: research
EMA: No Bivalent-Stroke Link; Presley's Cause of Death 'Deferred'; Handshakes Return
(MedPage Today) -- Note that some links may require subscriptions.
The European Medicines Agency said it has not seen any signal of a possible stroke risk related to the Pfizer-BioNTech bivalent COVID-19 vaccine. (Reuters)
Funds from pandemic...
Source: MedPage Today Infectious Disease - January 19, 2023 Category: Infectious Diseases Source Type: news
DeSantis Pushes Permanent Bans; Moderna RSV Vax Effective; Top Stroke Expert Dies
(MedPage Today) -- Note that some links may require subscriptions.
Florida Gov. Ron DeSantis (R) pushed to make permanent the state's bans on school mask mandates and vaccine requirements for local governments and businesses. (Tallahassee Democrat...
Source: MedPage Today Public Health - January 18, 2023 Category: American Health Source Type: news
CDC to investigate ‘safety signal’ for Pfizer’s updated COVID booster
Federal health officials are investigating whether there is a link between BioNTech BNTX, and Pfizer’s PFE, bivalent COVID-19 booster and stroke in seniors. The Centers and Disease Control and Prevention and the Food and Drug Administration said Friday they plan to investigate a…#veteransaffairs #medicaidservices #pfizers #fda #vsd #cdc #vaccines #modernasmrna #medicare #bntx
Source: Reuters: Health - January 17, 2023 Category: Consumer Health News Source Type: news
